FIELD: medicine.
SUBSTANCE: invention relates to field of medicine - ophthalmology. Medication for prevention and treatment of ophthalmlogical diseases contains active substance, gel-former, sodium chloride, sorbitol, buffer, conservative, water and disodium edentate. As active substance ethylmethylhydroxypyridine succinate is used; as gel-former - polyacrylic acid, hydroxyethylcellulose, sodium-carboxymethylcellulose, hydroxypropylcelulose or healon; as buffer phosphate buffer is used, which includes sodium hydrophosphate - 0.2-2.0% and potassium dihydrophosphate 0.05-1.0%, or citrate buffer, which includes sodium hydrocytate - 0.5-2.5% and sodium hydroxide 0.05-1.5%; as conservative - cetrimide.
EFFECT: increase of efficiency of antioxidative and antihypoxic protection.
4 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICINE USED FOR PREVENTION AND TREATMENT OF OPHTHALMOLOGIC DISEASES AND METHOD OF ITS PREPARATION | 2010 |
|
RU2442581C1 |
| OPHTHALMOLOGIC GEL OF TAURINE | 2016 |
|
RU2623205C1 |
| EYE DROPS USABLE WITH CONTACT LENSES | 2005 |
|
RU2292222C1 |
| OPHTHALMOLOGIC GEL AND METHOD OF ITS PREPARATION | 2007 |
|
RU2340327C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING EYE DISEASES RELATED TO EYE TISSUE METABOLIC DISEASE AND INFLAMMATORY EYE TISSUE INJURY | 2013 |
|
RU2521337C1 |
| EYE DROPS BASED ON COMPOSITION OF PHARMACEUTICALLY ACCEPTABLE ADDITIVE ACID SALTS AND METHYLETHYL PYRIDONOL AND TAURINE CONTAINING COMPOSITION OF GROUP B VITAMINS | 2013 |
|
RU2533276C1 |
| COMBINED OPHTHALMIC AGENT | 2019 |
|
RU2733392C1 |
| EYE DROPS BASED ON PHARMACEUTICALLY TOLERABLE ADDITIVE SALTS OF ACID AND METHYL ETHYL ENCEPHABOL CONTAINING COMPOSITION OF VITAMINS B | 2013 |
|
RU2528912C1 |
| METHOD OF EYE TREATING BURNS | 2012 |
|
RU2495651C1 |
| CONTACT LENS CARE SOLUTION | 2020 |
|
RU2755298C1 |
